Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT07555743. HopeStage can help you review the study, but cannot decide medical eligibility.
Not Yet RecruitingNCT07555743
Daridorexant for depression
This study is not yet recruiting in Spain. It is testing daridorexant for depression.
DepressionOtherFrom 18 Years to 99 Years
Key information made simple
This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand whether questionnaires and follow-up reports can improve sleep, daily rhythms, and longer-term stability. For people living with Depression, the gap between what sounds good on paper and what works in daily life is often important. If the findings are useful, they could help future care become more targeted, practical, and easier to trust. Taking part helps build the evidence that can improve understanding and care for others over time.
Your next step
The official record suggests in-person participation through a hospital, with sites including Hospital Universitari de Bellvitge in Barcelona. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually matching the main diagnosis, while common reasons not to take part include pregnancy or breastfeeding and active substance or alcohol problems that could affect the results. This is a later-stage study, which usually means the approach is being followed in broader real-world use.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- Institut d'Investigació Biomèdica de Bellvitge
- Sponsor type
- Research institute
- Main activity
- observational follow-up
- Intervention
- Not available
- Time commitment
- long follow-up or multiple visits
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Not Yet Recruiting
- Source
- Official registry link
Key study information
- Official title
- Efficacy and Safety of Daridorexant in Patients With Major Depressive Disorder and Insomnia
- Condition
- Insomnia; Major Depressive Disorder
- Study status
- Not Yet Recruiting
- Sponsor / lead affiliation
- Institut d'Investigació Biomèdica de Bellvitge
- Location / country
- Spain
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT07555743
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help improve understanding of your condition.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in Spain.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- Efficacy and Safety of Daridorexant in Patients With Major Depressive Disorder and Insomnia
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT07555743
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is Daridorexant for depression?
This study is exploring observational follow-up for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Institut d'Investigació Biomèdica de Bellvitge. Based on the sponsor name or official registry information, it appears to be a research institute. You should verify the details in the official registry record.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve observational follow-up, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me